Estrogenic Activity of Griffonianone C, an Isoflavone from the Root Bark of Millettia griffoniana: Regulation of the Expression of Estrogen Responsive Genes in Uterus and Liver of Ovariectomized Rats

Abstract

Griffonianone C (Griff C) is an isoflavone produced by Millettia griffoniana (Bail) and exhibits estrogenic properties in in vitro reporter gene assays. In order to validate its estrogenic potency in vivo, we administered subcutaneously Griff C (2, 10, or 20 mg/kg/d BW), 17β-estradiol (10 μg/kg/d BW) as positive control, and a vehicle control to ovariectomized Wistar rats. After three consecutive days of treatment animals were sacrificed 24 hours after receiving the last dose. The uteri and livers were excised, weighed and stored for mRNA expression analysis by real-time PCR. The uterine wet weight was not significantly increased by Griff C, although there was a trend towards an increase. In contrast, 17β-estradiol increased uterine wet weight 4.5-fold in comparison to the vehicle control. However, as revealed by real-time PCR Griff C affected the expression of estrogen-responsive genes in uterus and liver of ovariectomized rats. E2 induced a 550-fold stimulation of uterine C3 mRNA expression. Griff C at the dose 20 mg/kg/d BW caused a 50-fold up-regulation of complement C3 mRNA compared to the control. A significant increase in calcium binding protein 9-kilodalton mRNA expression was observed in the uterus of ovariectomized rats treated with E₂ (41-fold versus control) or 20 mg/kg/d BW of Griff C (25-fold versus control). In contrast, the expression of clusterin and progesterone receptor in the uterus was strongly decreased by both E2 and Griff C at the highest dose. We also found a repression of clusterin mRNA in the liver while carbonic anhydrase 2 and major acute phase protein were slightly up-regulated. In conclusion, Griff C showed a clear estrogenic action on uterine and hepatic tissues of ovariectomized rats, although its effect was less than the effect of estradiol. This suggests that some of the biological effects attributed to Millettia griffoniana are probably related to estrogen-mediated function.

Griffonianone C - Millettia griffoniana - Leguminosae - uterus - liver - Wistar rat - real-time PCR

References

• 1 Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.  Biochemistry. 2004;  43 2569-77.
• 2 Dagne E, Bekele A, Noguchi H, Shibuya M, Sankawa U. O-Geranylated and O-prenylated flavonoids from Milletia ferruginea .  Phytochemistry. 1990;  29 2671-3.
• 3 Dewick P M. The Flavonoids, advances in research since 1986. In: Harbone JB, editor The Flavonoids. New York; Chapman and Hall 1994: 117-238.
• 4 Yankep E, Mbafor J T, Fomum Z T, Steinbeck C, Messanga B B, Nyasse B. et al . Further isoflavonoid metabolites from Millettia griffoniana (Bail).  Phytochemistry. 2001;  56 363-8.
• 5 Wanda G J, Njamen D, Yankep E, Fotsing M T, Fomum Z T, Wober J. et al . Estrogenic properties of isoflavones derived from Millettia griffoniana .  Phytomedicine. 2006;  13 139-45.
• 6 Laws S C, Carey S A, Ferrell J M, Bodman G J, Cooper R L. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats.  Toxicol Sci. 2000;  54 154-67.
• 7 OECD. Third meeting of the validation management group for the screening and testing of endocrine disrupters (mammalian effects). Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology; 2001. http://www.oecd.org. 
• 8 Winer J A, Larue D T, Huang C L. Two systems of giant axon terminals in the cat medial geniculate body: convergence of cortical and GABAergic inputs.  J Comp Neurol. 1999;  413 181-97.
• 9 Zierau O, Geis R B, Tischer S, Schwab P, Metz P, Vollmer G. Uterine effects of the phytoestrogen 6-(1,1-dimethylallyl)naringenin in rats.  Planta Med. 2004;  70 590-3.
• 10 Diel P, Schmidt S, Vollmer G, Janning P, Upmeier A, Michna H. et al . Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens.  Arch Toxicol. 2004;  78 183-93.
• 11 Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity.  J Steroid Biochem Mol Biol. 2000;  73 1-10.
• 12 Tibbetts T A, Mendoza-Meneses M, O'Malley B W, Conneely O M. Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus.  Biol Reprod. 1998;  59 1143-52.
• 13 Kuiper G G, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S. et al . Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.  Endocrinology. 1997;  138 863-70.
• 14 Weihua Z, Saji S, Makinen S, Cheng G, Jensen E V, Warner M. et al . Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus.  Proc Natl Acad Sci USA. 2000;  97 5936-41.
• 15 Cooke P S, Buchanan D L, Young P, Setiawan T, Brody J, Korach K S. et al . Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium.  Proc Natl Acad Sci USA. 1997;  94 6535-40.
• 16 Newbold R R, Jefferson W N, Padilla-Banks E, Walker V R, Pena D S. Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay.  Reprod Toxicol. 2001;  15 245-52.
• 17 An B S, Kang S K, Shin J H, Jeung E B. Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol.  Mol Cell Endocrinol. 2002;  191 177-86.
• 18 Vollmer G, Schneider M R. The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model.  J Steroid Biochem Mol Biol. 1996;  58 103-15.
• 19 Guenette R S, Daehlin L, Mooibroek M, Wong K, Tenniswood M. Thanatogen expression during involution of the rat ventral prostate after castration.  J Androl. 1994;  15 200-11.
• 20 Diel P, Smolnikar K, Schulz T, Laudenbach-Leschowski U, Michna H, Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium.  Hum Reprod. 2001;  16 997-1006.
• 21 Wunsche W, Tenniswood M P, Schneider M R, Vollmer G. Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue.  Int J Cancer. 1998;  76 684-8.
• 22 Krisinger J, Setoyama T, Leung P C. Expression of calbindin-D9k in the early pregnant rat uterus: effects of RU 486 and correlation to estrogen receptor mRNA.  Mol Cell Endocrinol. 1994;  102 15-22.
• 23 Darwish H, Krisinger J, Furlow J D, Smith C, Murdoch F E, DeLuca H F. An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9K gene in rat uterus.  J Biol Chem. 1991;  266 551-8.
• 24 Hughes C L, Liu G, Beall S, Foster W G, Davis V. Effects of genistein or soy milk during late gestation and lactation on adult uterine organization in the rat.  Exp Biol Med. 2004;  229 108-17.
• 25 Bebington C, Doherty F J, Ndukwe G, Fleming S D. The progesterone receptor and ubiquitin are differentially regulated within the endometrial glands of the natural and stimulated cycle.  Mol Hum Reprod. 2000;  6 264-8.
• 26 Weihua Z, Andersson S, Cheng G, Simpson E R, Warner M, Gustafsson J A. Update on estrogen signaling.  FEBS Lett. 2003;  546 17-24.
• 27 Diel P, Hegele-Hartung C, Burton G, Kauser K, Fritzemeier K H. Tissue specific effects of estrogens on expression of COX II, iNOS, and IL-6 mRNA in V.Cava and uterus of ovex. rats. Freiburg; Annual Meeting of the German Endocrine Society 1996.
• 28 Curtis Hewitt S, Goulding E H, Eddy E M, Korach K S. Studies using the estrogen receptor alpha knockout uterus demonstrate that implantation but not decidualization-associated signaling is estrogen dependent.  Biol Reprod. 2002;  67 1268-77.
• 29 Schoultz B von, Carlstrom K. On the regulation of sex-hormone-binding globulin - a challenge of an old dogma and outlines of an alternative mechanism.  J Steroid Biochem. 1989;  32 327-34.
• 30 Ohkubo H, Nakayama K, Tanaka T, Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity.  J Biol Chem. 1986;  261 319-23.
• 31 Bell S C, Patel S R, Jackson J A, Waites G T. Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein.  J Endocrinol. 1988;  118 317-28.
• 32 Molnar P, Murphy L J. Effects of oestrogen on rat uterine expression of insulin-like growth factor-binding proteins.  J Mol Endocrinol. 1994;  13 59-67.
• 33 Kachra Z, Yang C R, Murphy L J, Posner B I. The regulation of insulin-like growth factor-binding protein 1 messenger ribonucleic acid in cultured rat hepatocytes: the roles of glucagon and growth hormone.  Endocrinology. 1994;  135 1722-8.
• 34 Luo J, Reid R E, Murphy L J. Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat.  Endocrinology. 1990;  127 1456-62.
• 35 Calabrese E J, Baldwin L A. The hormetic dose-response model is more common than the threshold model in toxicology.  Toxicol Sci. 2003;  71 246-50.